Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lidocaine during remimazolam anesthesia induction
ChiCTR2200066806Phase 4Not yet recruiting
- Sponsor
- Renmin Hospital, Hubei University of Medicine
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial comparing Remimazolam + normal saline with Remimazolam + lidocaine (2 arms). Primary endpoint: Cycle fluctuations (hemodynamic fluctuations). Planned start Jan 2023; status: not yet recruiting.
02
Drugs
lidocaineremimazolam
Beyond the preview
Go deeper on ChiCTR2200066806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066806.